Tandem Investment Advisors Inc. Sells 963 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Tandem Investment Advisors Inc. trimmed its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 63.3% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 559 shares of the healthcare conglomerate's stock after selling 963 shares during the quarter. Tandem Investment Advisors Inc.'s holdings in UnitedHealth Group were worth $293,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently added to or reduced their stakes in the company. Smart Money Group LLC bought a new position in shares of UnitedHealth Group during the 1st quarter valued at $200,000. Resonant Capital Advisors LLC grew its holdings in shares of UnitedHealth Group by 13.9% during the 1st quarter. Resonant Capital Advisors LLC now owns 2,995 shares of the healthcare conglomerate's stock worth $1,569,000 after purchasing an additional 365 shares in the last quarter. Teacher Retirement System of Texas boosted its stake in UnitedHealth Group by 10.3% during the first quarter. Teacher Retirement System of Texas now owns 432,078 shares of the healthcare conglomerate's stock worth $226,301,000 after buying an additional 40,310 shares in the last quarter. R.H. Investment Group LLC raised its stake in shares of UnitedHealth Group by 3.4% in the 1st quarter. R.H. Investment Group LLC now owns 7,119 shares of the healthcare conglomerate's stock valued at $3,729,000 after buying an additional 234 shares in the last quarter. Finally, Revisor Wealth Management LLC bought a new position in UnitedHealth Group during the first quarter worth about $595,000. Institutional investors own 87.86% of the company's stock.

Insider Activity at UnitedHealth Group

In related news, CEO Stephen J. Hemsley acquired 86,700 shares of UnitedHealth Group stock in a transaction that occurred on Friday, May 16th. The stock was bought at an average price of $288.57 per share, with a total value of $25,019,019.00. Following the transaction, the chief executive officer directly owned 679,493 shares in the company, valued at approximately $196,081,295.01. This represents a 14.63% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Timothy Patrick Flynn bought 1,533 shares of the business's stock in a transaction on Wednesday, May 14th. The shares were acquired at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the purchase, the director owned 6,033 shares in the company, valued at approximately $1,935,386.40. The trade was a 34.07% increase in their position. The disclosure for this purchase can be found here. Insiders bought a total of 109,408 shares of company stock valued at $31,607,768 in the last quarter. 0.28% of the stock is currently owned by company insiders.

UnitedHealth Group Stock Performance

UnitedHealth Group stock traded up $1.13 during mid-day trading on Thursday, reaching $308.69. 6,161,145 shares of the company's stock were exchanged, compared to its average volume of 7,543,771. The firm has a market capitalization of $280.03 billion, a PE ratio of 12.93, a P/E/G ratio of 1.46 and a beta of 0.45. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.71. The business's fifty day simple moving average is $329.50 and its 200 day simple moving average is $450.21. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The company had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. During the same quarter in the previous year, the firm posted $6.91 earnings per share. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were issued a dividend of $2.21 per share. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a yield of 2.86%. The ex-dividend date of this dividend was Monday, June 16th. UnitedHealth Group's dividend payout ratio is currently 37.02%.

Analyst Ratings Changes

Several analysts have recently commented on the stock. JPMorgan Chase & Co. increased their price target on shares of UnitedHealth Group from $405.00 to $418.00 and gave the company an "overweight" rating in a research note on Friday, June 20th. KeyCorp cut their price target on shares of UnitedHealth Group from $450.00 to $400.00 and set an "overweight" rating on the stock in a research note on Monday, June 2nd. Deutsche Bank Aktiengesellschaft decreased their target price on shares of UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating for the company in a research report on Wednesday, May 14th. Wells Fargo & Company restated an "overweight" rating on shares of UnitedHealth Group in a research note on Friday, June 6th. Finally, Piper Sandler dropped their price target on shares of UnitedHealth Group from $552.00 to $353.00 and set an "overweight" rating for the company in a research report on Tuesday, June 3rd. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $415.57.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.